Certain Common Stock of Karuna Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-SEP-2022.
Details:
Executive officers and directors of the company have agreed with the underwriters, subject to certain exceptions, not to dispose of or hedge any of common stock or securities convertible into or exchangeable for shares of common stock during the period from the date of the prospectus supplement continuing through the date 45 days, after the date of the prospectus supplement, except with the prior written consent of Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC.